Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer
-
Stock Symbol
-
INAB on Nasdaq
There are no Buy or Sell transactions made by Kate Rochlin since 11/21/2023
Holdings reported by Kate Rochlin for In8 Bio, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
42.9K |
$18.1K |
$1.03 |
Oct 4, 2024 |
Direct |
|
|
Employee Stock Option (right to buy) |
250K |
|
|
Sep 4, 2024 |
Direct |
Common Stock |
|
Employee Stock Option (right to buy) |
186K |
|
|
Feb 7, 2024 |
Direct |
Common Stock |
|
Series C Warrants (right to buy) |
25.3K |
|
|
Oct 4, 2024 |
Direct |
Common Stock |
|
Series A Warrants (right to buy) |
12.3K |
|
|
Oct 4, 2024 |
Direct |
Common Stock |
|
Series B Warrants (right to buy) |
12.3K |
|
|
Dec 13, 2023 |
Direct |
Common Stock |
|
Transactions reported by Kate Rochlin for In8 Bio, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.